ADIPOQ and Hyperinsulinemia: Discordant responses (between PIV and Ach) have previously been reported [17, 44] and in our model, the adaptive PIV response is likely mediated by the combined action of mild hyperinsulinemia and improvements in adiponectin bioavailability, which enlist PI3K- and NOS-dependent vasodilation.